Cointime

Fibralign Corporation

company

About

Fibralign Corporation is an advanced biomedical devices company.

  • 1 - 10

Highlights

Total Funding Amount
$179.96K
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$179.96K
Industries
Biotechnology,Clinical Trials,Medical,Medical Device,Therapeutics
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Fibralign Corporation utilizes Nanoweave® a proprietary scaffolding technology to develop advanced biomedical devices.

Fibralign has launched its first product, the BioBridge® Collagen Matrix, and is now engaging in clinical studies to evaluate its use for treating and preventing secondary lymphedema, as well as advancing R&D development for new applications for treating ischemia and novel delivery devices for use with stem cells and gene therapy.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$179.96K
Fibralign Corporation has raised a total of $179.96K in funding over 2 rounds. Their latest funding was raised on Dec 18, 2012 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 18, 2012 Grant $179.96K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Fibralign Corporation is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Cointime
İçerikler
Şirket.